cytokine a Search Results


human high sensitivity cytokine premixed kit  (R&D Systems)
94
R&D Systems human high sensitivity cytokine premixed kit
Human High Sensitivity Cytokine Premixed Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cytokine+a/pm36154663-116-15-24?v=R%26D+Systems
Average 94 stars, based on 1 article reviews
human high sensitivity cytokine premixed kit - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier
fcstm09  (R&D Systems)
93
R&D Systems fcstm09
Fcstm09, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cytokine+a/pm30243504-87-32-41?v=R%26D+Systems
Average 93 stars, based on 1 article reviews
fcstm09 - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier
human cytokine premixed multi analyte kit  (R&D Systems)
94
R&D Systems human cytokine premixed multi analyte kit
AHR pathway modulation alters IL1B, IL4, IL6, and IL10 expression (FC, Luminex) in PDAC PBMCs. <t>Cytokine</t> expression was assessed at mRNA, soluble, and intracellular levels in M1 and M2 monocytes following treatment with Carbidopa, Tapinarof, or BAY. Samples were stratified by baseline AHR expression. CTRL refers to untreated PDAC PBMCs stimulated with LPS but without AHR modulators or tumor co-culture. Healthy indicates LPS-stimulated PBMCs from non-cancer donors, and co-cultured refers to healthy PBMCs indirectly co-cultured with BxPC-3 cells. Sample numbers (n) varied between assays and AHR expression groups due to differences in PBMC yield and viability (typically n = 1–13 for PDAC High/Medium AHR, n = 2–13 for PDAC Low AHR, and n = 11–14 for healthy donors; see for details). Color coding: red = upregulated; blue = downregulated; white = no significant change; ↑/↓ indicate directional changes; Δ – significant vs. CTRL PDAC; *p < 0.05 vs. healthy; **p < 0.05 vs. co-cultured; NS, not significant.
Human Cytokine Premixed Multi Analyte Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cytokine+a/pmc12675361-97-29-34?v=R%26D+Systems
Average 94 stars, based on 1 article reviews
human cytokine premixed multi analyte kit - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier
human cytokine base kit a  (R&D Systems)
96
R&D Systems human cytokine base kit a
AHR pathway modulation alters IL1B, IL4, IL6, and IL10 expression (FC, Luminex) in PDAC PBMCs. <t>Cytokine</t> expression was assessed at mRNA, soluble, and intracellular levels in M1 and M2 monocytes following treatment with Carbidopa, Tapinarof, or BAY. Samples were stratified by baseline AHR expression. CTRL refers to untreated PDAC PBMCs stimulated with LPS but without AHR modulators or tumor co-culture. Healthy indicates LPS-stimulated PBMCs from non-cancer donors, and co-cultured refers to healthy PBMCs indirectly co-cultured with BxPC-3 cells. Sample numbers (n) varied between assays and AHR expression groups due to differences in PBMC yield and viability (typically n = 1–13 for PDAC High/Medium AHR, n = 2–13 for PDAC Low AHR, and n = 11–14 for healthy donors; see for details). Color coding: red = upregulated; blue = downregulated; white = no significant change; ↑/↓ indicate directional changes; Δ – significant vs. CTRL PDAC; *p < 0.05 vs. healthy; **p < 0.05 vs. co-cultured; NS, not significant.
Human Cytokine Base Kit A, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cytokine+a/pm36979966-61-14-19?v=R%26D+Systems
Average 96 stars, based on 1 article reviews
human cytokine base kit a - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier
human premixed magnetic screening assay  (R&D Systems)
94
R&D Systems human premixed magnetic screening assay
AHR pathway modulation alters IL1B, IL4, IL6, and IL10 expression (FC, Luminex) in PDAC PBMCs. <t>Cytokine</t> expression was assessed at mRNA, soluble, and intracellular levels in M1 and M2 monocytes following treatment with Carbidopa, Tapinarof, or BAY. Samples were stratified by baseline AHR expression. CTRL refers to untreated PDAC PBMCs stimulated with LPS but without AHR modulators or tumor co-culture. Healthy indicates LPS-stimulated PBMCs from non-cancer donors, and co-cultured refers to healthy PBMCs indirectly co-cultured with BxPC-3 cells. Sample numbers (n) varied between assays and AHR expression groups due to differences in PBMC yield and viability (typically n = 1–13 for PDAC High/Medium AHR, n = 2–13 for PDAC Low AHR, and n = 11–14 for healthy donors; see for details). Color coding: red = upregulated; blue = downregulated; white = no significant change; ↑/↓ indicate directional changes; Δ – significant vs. CTRL PDAC; *p < 0.05 vs. healthy; **p < 0.05 vs. co-cultured; NS, not significant.
Human Premixed Magnetic Screening Assay, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cytokine+a/10__1515_slash_rrlm___2016___0044-58-18-23?v=R%26D+Systems
Average 94 stars, based on 1 article reviews
human premixed magnetic screening assay - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier
sensitivity base kit hs cytokine  (R&D Systems)
93
R&D Systems sensitivity base kit hs cytokine
AHR pathway modulation alters IL1B, IL4, IL6, and IL10 expression (FC, Luminex) in PDAC PBMCs. <t>Cytokine</t> expression was assessed at mRNA, soluble, and intracellular levels in M1 and M2 monocytes following treatment with Carbidopa, Tapinarof, or BAY. Samples were stratified by baseline AHR expression. CTRL refers to untreated PDAC PBMCs stimulated with LPS but without AHR modulators or tumor co-culture. Healthy indicates LPS-stimulated PBMCs from non-cancer donors, and co-cultured refers to healthy PBMCs indirectly co-cultured with BxPC-3 cells. Sample numbers (n) varied between assays and AHR expression groups due to differences in PBMC yield and viability (typically n = 1–13 for PDAC High/Medium AHR, n = 2–13 for PDAC Low AHR, and n = 11–14 for healthy donors; see for details). Color coding: red = upregulated; blue = downregulated; white = no significant change; ↑/↓ indicate directional changes; Δ – significant vs. CTRL PDAC; *p < 0.05 vs. healthy; **p < 0.05 vs. co-cultured; NS, not significant.
Sensitivity Base Kit Hs Cytokine, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cytokine+a/pmc11255846-311-30-39?v=R%26D+Systems
Average 93 stars, based on 1 article reviews
sensitivity base kit hs cytokine - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

Image Search Results


AHR pathway modulation alters IL1B, IL4, IL6, and IL10 expression (FC, Luminex) in PDAC PBMCs. Cytokine expression was assessed at mRNA, soluble, and intracellular levels in M1 and M2 monocytes following treatment with Carbidopa, Tapinarof, or BAY. Samples were stratified by baseline AHR expression. CTRL refers to untreated PDAC PBMCs stimulated with LPS but without AHR modulators or tumor co-culture. Healthy indicates LPS-stimulated PBMCs from non-cancer donors, and co-cultured refers to healthy PBMCs indirectly co-cultured with BxPC-3 cells. Sample numbers (n) varied between assays and AHR expression groups due to differences in PBMC yield and viability (typically n = 1–13 for PDAC High/Medium AHR, n = 2–13 for PDAC Low AHR, and n = 11–14 for healthy donors; see for details). Color coding: red = upregulated; blue = downregulated; white = no significant change; ↑/↓ indicate directional changes; Δ – significant vs. CTRL PDAC; *p < 0.05 vs. healthy; **p < 0.05 vs. co-cultured; NS, not significant.

Journal: Frontiers in Immunology

Article Title: Baseline AHR expression shapes immune response to pharmacological modulation in PBMCs from pancreatic cancer patients

doi: 10.3389/fimmu.2025.1655258

Figure Lengend Snippet: AHR pathway modulation alters IL1B, IL4, IL6, and IL10 expression (FC, Luminex) in PDAC PBMCs. Cytokine expression was assessed at mRNA, soluble, and intracellular levels in M1 and M2 monocytes following treatment with Carbidopa, Tapinarof, or BAY. Samples were stratified by baseline AHR expression. CTRL refers to untreated PDAC PBMCs stimulated with LPS but without AHR modulators or tumor co-culture. Healthy indicates LPS-stimulated PBMCs from non-cancer donors, and co-cultured refers to healthy PBMCs indirectly co-cultured with BxPC-3 cells. Sample numbers (n) varied between assays and AHR expression groups due to differences in PBMC yield and viability (typically n = 1–13 for PDAC High/Medium AHR, n = 2–13 for PDAC Low AHR, and n = 11–14 for healthy donors; see for details). Color coding: red = upregulated; blue = downregulated; white = no significant change; ↑/↓ indicate directional changes; Δ – significant vs. CTRL PDAC; *p < 0.05 vs. healthy; **p < 0.05 vs. co-cultured; NS, not significant.

Article Snippet: The concentrations of cytokines IL-1β, IL4, and IL10 were quantified in the culture media collected after 24 h of healthy and PDAC PBMCs incubation using magnetic bead–based multiplex assays (Human Cytokine Premixed Multi-Analyte Kit, R&D Systems, Minneapolis, MN, USA) and analyzed using a Luminex 100 analyzer (Luminex Corporation, Cat# L100-XPONENT, Austin, TX, USA; RRID: SCR_018025).

Techniques: Expressing, Luminex, Co-Culture Assay, Cell Culture